DSM-Firmenich AG (FRA:ZX6)

Germany flag Germany · Delayed Price · Currency is EUR
60.62
-0.94 (-1.53%)
At close: Mar 27, 2026
Market Cap15.21B -39.5%
Revenue (ttm)9.03B -28.5%
Net Income-1.11B
EPS-4.27
Shares Outn/a
PE Ration/a
Forward PE19.81
Dividend2.50 (4.19%)
Ex-Dividend DateMay 8, 2025
Volumen/a
Average Volume224
Open60.94
Previous Close61.56
Day's Range60.62 - 60.94
52-Week Range55.26 - 99.58
Betan/a
RSI52.23
Earnings DateJul 30, 2026

About DSM-Firmenich AG

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and s... [Read more]

Industry Chemicals and Allied Products
Founded 1902
Employees 26,873
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol ZX6

Financial Performance

Financial Statements

News

DSM-Firmenich AG (DSFIY) Shareholder/Analyst Call Transcript

DSM-Firmenich AG (DSFIY) Shareholder/Analyst Call Transcript

11 days ago - Seeking Alpha

dsm-firmenich outlines action plan at Investor Event to accelerate performance, following completion of transformation

Press Release dsm-firmenich outlines action plan at Investor Event to accelerate performance, following completion of transformation Kaiseraugst (Switzerland), Maastricht (Netherlands), March 12, 2026...

17 days ago - GlobeNewsWire

dsm-firmenich announces share repurchase program to cover share plans and reduce capital

Press Release dsm-firmenich announces share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), March 12, 2026 dsm-firmenich, innovators in ...

17 days ago - GlobeNewsWire

dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program

Press Release dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program Kaiseraugst (Switzerland), Maastricht (Netherlands), February 26 2026 dsm-firmenich, i...

4 weeks ago - GlobeNewsWire

dsm-firmenich publishes 2025 Integrated Annual Report

Press Release dsm-firmenich publishes 2025 Integrated Annual Report Kaiseraugst (Switzerland), Maastricht (Netherlands), February 20, 2026 dsm-firmenich today announces the publication of its Integrat...

5 weeks ago - GlobeNewsWire

dsm-firmenich issues €1.5 billion long-term bonds

Press Release dsm-firmenich issues €1.5 billion long-term bonds Kaiseraugst (Switzerland), Maastricht (Netherlands), February 17 2026 dsm-firmenich today announces the successful launch of a €1.5 bill...

5 weeks ago - GlobeNewsWire

DSM-Firmenich AG (KDSKF) Q4 2025 Earnings Call Transcript

DSM-Firmenich AG (KDSKF) Q4 2025 Earnings Call Transcript

6 weeks ago - Seeking Alpha

dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition & Health (ANH)

Press Release dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition & Health (ANH) Kaiseraugst (Switzerland), Maastricht (Netherlands), February...

6 weeks ago - GlobeNewsWire

DSM-Firmenich to Sell Animal Nutrition Unit to CVC in $2.6 Billion Deal

The sale to CVC Capital Partners marks the final step in its plan to fully focus on human nutrition, health and beauty.

6 weeks ago - WSJ

DSM-Firmenich to sell animal health business to CVC Capital

Chemicals company DSM-Firmenich has agreed to sell its Animal Nutrition & Health business to CVC Capital for an enterprise value of around 2.2 billion euros ($2.6 billion), it said on Monday.

6 weeks ago - Reuters

dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners

Press Release dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners Kaiseraugst (Switzerland), Maastricht (Netherlands), February 9, 2026 dsm-firmenich, innovat...

6 weeks ago - GlobeNewsWire

dsm-firmenich appoints Nikeisha van Sleeuwen as Chief Human Resources Officer

Press Release dsm-firmenich appoints Nikeisha van Sleeuwen as Chief Human Resources Officer Kaiseraugst (Switzerland), Maastricht (Netherlands), January 14, 2026 dsm-firmenich, the leading innovator i...

2 months ago - GlobeNewsWire

Goldman Sachs International Equity ESG Fund Q3 2025 Portfolio Review

Goldman Sachs International Equity ESG Fund initiated a position in ING Group (2.6%), a Dutch global financial institution. We initiated a position in Air Liquide (2.0%), which produces, markets, and ...

3 months ago - Seeking Alpha

DSM-Firmenich: High-Quality Value Play

DSM-Firmenich, formed by the merger of DSM and Firmenich, faces challenges post-merger, including the sale of the ANH division. The stock has experienced a significant price decline, presenting a pote...

4 months ago - Seeking Alpha

DSM-Firmenich AG (KDSKF) Q3 2025 Sales Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q3 2025 Sales Call October 30, 2025 4:00 AM EDT Company Participants Dave Huizing - Senior Vice President of Investor Relations Dimitri de Vreeze - Chief Executive Officer...

5 months ago - Seeking Alpha

dsm-firmenich Q3 2025 trading update

Press Release Kaiseraugst (Switzerland), Maastricht (Netherlands), October 30, 2025 dsm-firmenich Q3 2025 trading update Management Report Q3 2025 highlights Solid growth and strong step up in Adjuste...

5 months ago - GlobeNewsWire

Artisan International Value Fund Q3 2025 Portfolio Update

Major joint customer announcements about new products and significant future orders combined with strong demand for basic memory semiconductors drove renewed interest in Samsung Electronics stock. ABB...

5 months ago - Seeking Alpha

DSM-Firmenich: A Widening Moat At A Discount

DSM-Firmenich leverages scale, proprietary R&D, and customer stickiness to enhance its position in specialty ingredients, flavors, and fragrances. DSM-Firmenich delivered 7% organic sales growth and a...

6 months ago - Seeking Alpha

dsm-firmenich strengthens its Executive Committee for future growth as a consumer-focused company

Press Release dsm-firmenich strengthens its Executive Committee for future growth as a consumer-focused company Kaiseraugst (Switzerland), Maastricht (Netherlands), September 1, 2025 dsm-firmenich is ...

7 months ago - GlobeNewsWire

DSM-Firmenich AG (DSFIY) Q2 2025 Earnings Call Transcript

DSM-Firmenich AG (OTCQX:DSFIY) Q2 2025 Earnings Conference Call July 31, 2025 3:00 AM ET Company Participants Dave Huizing - Senior Vice President of Investor Relations Dimitri de Vreeze - Chief Execu...

8 months ago - Seeking Alpha

dsm-firmenich reports H1 2025 results

Press Release Kaiseraugst (Switzerland), Maastricht (Netherlands), July 31, 2025 dsm-firmenich reports H1 2025 results Management Report H1 2025 highlights Good first half of the year, with good organ...

8 months ago - GlobeNewsWire

Dsm-firmenich's animal feed unit sale attracts three final bidders, Dutch paper reports

Dsm-firmenich's is close to selling its animal nutrition business, with final bids expected from private equity firms CVC , Apollo and Dutch rival Nutreco, Dutch newspaper Financieele Dagblad reported...

9 months ago - Reuters

dsm-firmenich announces redemption of €750 million hybrid bond

Press Release dsm-firmenich announces redemption of € 750 million hybrid bond Kaiseraugst (Switzerland), Maastricht (Netherlands), July 1, 2025 dsm-firmenich, innovators in nutrition, health, and beau...

9 months ago - GlobeNewsWire

dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion

Press Release dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion Kaiseraugst (Switzerland), Maastricht (Netherlands), June 27, 2025 dsm-firmenich, innovators ...

9 months ago - GlobeNewsWire

dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion

Press Release dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion Kaiseraugst (Switzerland), Maastricht (Netherlands), June 2, 2025 dsm-firmenich, innovato...

10 months ago - GlobeNewsWire